These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 7195225

  • 1. The absorption, metabolism and excretion of (14C)-AR-L 115 BS in the baboon.
    Cameron BD, Draffan GH, Dunsire JP, Zimmer A.
    Arzneimittelforschung; 1981; 31(1a):217-20. PubMed ID: 7195225
    [Abstract] [Full Text] [Related]

  • 2. [Pharmacokinetics of AR-L 115 BS in rhesus monkeys (author's transl)].
    Mierau J.
    Arzneimittelforschung; 1981; 31(1a):221-5. PubMed ID: 7195226
    [Abstract] [Full Text] [Related]

  • 3. [Pharmacokinetics of AR-L 115 BS in rabbits and dogs].
    Zimmer A, Hammer R.
    Arzneimittelforschung; 1981; 31(1a):212-6. PubMed ID: 7195224
    [Abstract] [Full Text] [Related]

  • 4. [Pharmacokinetics of AR-L 115 BS in the rat (author's transl)].
    Busch U.
    Arzneimittelforschung; 1981; 31(1a):204-9. PubMed ID: 7195222
    [Abstract] [Full Text] [Related]

  • 5. [AR-L 115 BS, comparison of human metabolite pattern and biotransformation with other species].
    Roth W, Prox A, Reuter A, Schmid J, Zimmer A, Zipp H.
    Arzneimittelforschung; 1981; 31(1a):232-5. PubMed ID: 7195228
    [Abstract] [Full Text] [Related]

  • 6. [Human pharmacokinetics of AR-L 115 BS (author's transl)].
    Roth W, Zimmer A, Busch U.
    Arzneimittelforschung; 1981; 31(1a):236-9. PubMed ID: 7195229
    [Abstract] [Full Text] [Related]

  • 7. [Comparison of blood levels, excretion and metabolite pattern in rats non-pretreated and pretreated with subacute doses of AR-L 115 BS].
    Busch U.
    Arzneimittelforschung; 1981; 31(1a):209-12. PubMed ID: 7195223
    [Abstract] [Full Text] [Related]

  • 8. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
    Fujii T, Matsumoto S, Amejima H, Hatoyama T, Nakao M, Kagemoto A, Tanaka K, Miyazaki H.
    Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
    [Abstract] [Full Text] [Related]

  • 9. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S, Tagawa M, Amejima H, Nakao M, Kagemoto A, Fujii T, Miyazaki H, Sekine Y.
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [Abstract] [Full Text] [Related]

  • 10. [Animal studies on the tolerability of AR-L 115 BS (author's transl)].
    Schneider P, Bauer M, Eckenfels A, Lehmann H, Lützen L, Ueberberg H.
    Arzneimittelforschung; 1981 Oct; 31(1a):226-32. PubMed ID: 7195227
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetic study of [14C]flutrimazole after oral and intravenous administration in dogs. Comparison with clotrimazole.
    Conte L, Ramis J, Mis R, Vilageliu J, Basi N, Forn J.
    Arzneimittelforschung; 1992 Jun; 42(6):854-8. PubMed ID: 1418045
    [Abstract] [Full Text] [Related]

  • 12. Comparative cardiovascular effects of three benzimidazole derivatives, AR-L 57 BS, AR-L 100 BS, and AR-L 115 BS.
    Diederen W, Kadatz R.
    Arzneimittelforschung; 1981 Jun; 31(1a):141-6. PubMed ID: 7195207
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
    Okuyama Y, Momota K, Morino A.
    Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats.
    Duchêne P, Giudicelli MD, Neau B, Gronfier A, Firmin Y, Villax P, Saivin S, Houin G.
    Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879
    [Abstract] [Full Text] [Related]

  • 15. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP, Hartnagel RE, Osimitz TG, Llanso S.
    Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
    [Abstract] [Full Text] [Related]

  • 16. [Pharmacokinetics and metabolite pattern of clenbuterol in the rat].
    Kopitar Z, Zimmer A.
    Arzneimittelforschung; 1976 Feb; 26(7a):1435-41. PubMed ID: 1036935
    [Abstract] [Full Text] [Related]

  • 17. Absorption, metabolism, and excretion of [14C]imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjects.
    Ohmori S, Miura M, Toriumi C, Satoh Y, Ooie T.
    Drug Metab Dispos; 2007 Sep; 35(9):1624-33. PubMed ID: 17567733
    [Abstract] [Full Text] [Related]

  • 18. Metabolism of ethynodiol diacetate in the rhesus monkey before and after administration of rifampicin.
    Lewis CJ, Vose CW, Spalton PN, Ford GC, Haskins NJ, Palmer RF.
    Xenobiotica; 1980 Sep; 10(9):705-13. PubMed ID: 7445531
    [Abstract] [Full Text] [Related]

  • 19. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T, Nakajima Y, Mizobuchi M, Inazawa K, Kanazu T, Kadono K, Ohkawa T, Iwatani K.
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [Abstract] [Full Text] [Related]

  • 20. [Studies on pharmacokinetics and biotransformation of ipratropiumbromide in man (author's transl)].
    Adlung J, Höhle KD, Zeren S, Wahl D.
    Arzneimittelforschung; 1976 Oct; 26(5a):1005-10. PubMed ID: 134721
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.